Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 19, keine Gesamtzahl für „section“
Suchtreffer
Begriffe & Kennungen
Cancidas (previously Caspofungin MSD) · 4.8 · Caspofungin has also been evaluated at 150 mg daily (for up to 51 days) in 100 adult patients (see section 5.1
Eintrag öffnenCapecitabine Accord · 4.8 · Cardiotoxicity (see section 4.4) In addition to the ADRs described in tables 4 and 5, the following ADRs with
Eintrag öffnenCapecitabine Accord · 4.8 · Diarrhoea (see section 4.4) Capecitabine can induce the occurrence of diarrhoea, which has been observed in up
Eintrag öffnenCapecitabine Accord · 4.8 · Elderly patients (see section 4.2) An analysis of safety data in patients ≥ 60 years of age treated with capec
Eintrag öffnenCapecitabine Accord · 4.8 · Hand-foot syndrome (HFS) (see section 4.4) For the capecitabine dose of 1250 mg/m2 twice daily on days 1 to 14
Eintrag öffnenCapecitabine Accord · 4.8 · Patients with renal impairment (see section 4.2, 4.4, and 5.2): An analysis of safety data in patients treated
Eintrag öffnenCapecitabine Medac · 4.8 · Cardiotoxicity (see section 4.4) In addition to the ADRs described in tables 4 and 5, the following ADRs with
Eintrag öffnenCapecitabine Medac · 4.8 · Diarrhoea (see section 4.4) Capecitabine can induce the occurrence of diarrhoea, which has been observed in up
Eintrag öffnenCapecitabine Medac · 4.8 · Elderly patients (see section 4.2) An analysis of safety data in patients ≥ 60 years of age treated with capec
Eintrag öffnenCapecitabine Medac · 4.8 · HFS (see section 4.4) For the capecitabine dose of 1,250 mg/m² twice daily on days 1 to 14 every 3 weeks, a fr
Eintrag öffnenCapecitabine Medac · 4.8 · Patients with renal impairment (see section 4.2, 4.4, and 5.2) An analysis of safety data in patients treated
Eintrag öffnenCapecitabine Teva · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 or fluorouracil,
Eintrag öffnenCapecitabine Teva · 4.8 · Cardiotoxicity (see section 4.4)
Eintrag öffnenCapecitabine Teva · 4.8 · Diarrhoea (see section 4.4)
Eintrag öffnenCapecitabine Teva · 4.8 · Elderly patients (see section 4.2)
Eintrag öffnenCapecitabine Teva · 4.8 · Hand-foot syndrome (see section 4.4)
Eintrag öffnenCapecitabine Teva · 4.8 · Patients with renal impairment (see section 4.2, 4.4, and 5.2)
Eintrag öffnenCarbaglu · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 . Breast-feeding du
Eintrag öffnenCarvykti · 4.3 · Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1. Contraindicatio
Eintrag öffnenCasgevy · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnen